Skip to main navigation Skip to search Skip to main content

In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates

  • Ami Patel
  • , Kyle Rosenke
  • , Elizabeth M. Parzych
  • , Friederike Feldmann
  • , Suman Bharti
  • , Amanda J. Griffin
  • , Blake Schouest
  • , Matt Lewis
  • , Jihae Choi
  • , Neethu Chokkalingam
  • , Viviane Machado
  • , Brian J. Smith
  • , Drew Frase
  • , Ali R. Ali
  • , Jamie Lovaglio
  • , Brian Nguyen
  • , Patrick W. Hanley
  • , Susanne N. Walker
  • , Ebony N. Gary
  • , Abhijeet Kulkarni
    • Allison Generotti, Joseph R. Francica, Kim Rosenthal, Daniel W. Kulp, Mark T. Esser, Trevor R.F. Smith, Carl Shaia, David B. Weiner, Heinz Feldmann
  • Wistar Institute
  • Liverpool School of Tropical Medicine
  • National Institutes of Health
  • Inovio Pharmaceuticals
  • AstraZeneca

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology